+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Radiotherapy Market Research Report by Product, Procedure, Application, End-User, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030

  • PDF Icon

    Report

  • 146 Pages
  • January 2023
  • Region: United States
  • 360iResearch™
  • ID: 5723110
The United States Radiotherapy Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States Radiotherapy Market.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the United States Radiotherapy Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the United States Radiotherapy Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The United States Radiotherapy Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the United States Radiotherapy Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the United States Radiotherapy Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market is studied across Conventional Cobalt-60 Teletherapy Units, Conventional Linear Accelerators, Electron-Emitting High-Energy Linear Accelerators, External Beam Radiotherapy, Internal Beam Radiotherapy or Brachytherapy, Particle Therapy Systems, Stereotactic Advanced Electron or Cobalt-60 Linear Accelerators, and Systemic Radiotherapy. The Internal Beam Radiotherapy or Brachytherapy is is further studied across Afterloaders, Applicators, and IORT Systems. The Particle Therapy Systems is is further studied across Cyclotrons, Synchrocyclotron, and Synchrotrons. The Stereotactic Advanced Electron or Cobalt-60 Linear Accelerators is is further studied across CyberKnife, Gamma Knife, and TomoTherapy. The Systemic Radiotherapy is is further studied across Iobenguane (I-131), Rhenium-186, and Samarium-153.
  • Based on Procedure, the market is studied across External Beam Radiotherapy, Instillation Radiotherapy, Internal Beam Radiotherapy or Brachytherapy, Intravenous Radiotherapy, Oral Radiotherapy, and Systemic Radiotherapy. The External Beam Radiotherapy is is further studied across 3D Conformal Radiotherapy, Image-Guided Radiotherapy, Intensity-Modulated Radiotherapy, Particle Therapy, and Stereotactic Therapy. The Internal Beam Radiotherapy or Brachytherapy is is further studied across High-Dose-Rate Brachytherapy, Low-Dose-Rate Brachytherapy, and Pulsed-Dose-Rate Brachytherapy.
  • Based on Application, the market is studied across Breast Cancer, Cervical Cancer, Colorectal Cancer, Gynecological Cancer, Head & Neck Cancer, Lung Cancer, Penile Cancer, and Prostate Cancer.
  • Based on End-User, the market is studied across Hospitals and Independent Radiotherapy Centers.
  • Based on State, the market is studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the United States Radiotherapy Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The United States Radiotherapy Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The United States Radiotherapy Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The United States Radiotherapy Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Radiotherapy Market, including Accuray Incorporated, Becton, Dickinson and Company, Elekta AB, General Electric Company, IBA Worldwide, IntraOp Medical, Inc., Koninklijke Philips N.V., Leo Cancer Care, Mevion Medical Systems, Panacea Medical Technologies Pvt. Ltd., Qfix, Radiology Oncology Systems, Varian Medical Systems, Inc., ViewRay Technologies, Inc., and ZEISS Group.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Radiotherapy Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Radiotherapy Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Radiotherapy Market?
4. What is the competitive strategic window for opportunities in the United States Radiotherapy Market?
5. What are the technology trends and regulatory frameworks in the United States Radiotherapy Market?
6. What is the market share of the leading vendors in the United States Radiotherapy Market?
7. What modes and strategic moves are considered suitable for entering the United States Radiotherapy Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising number of cancer patients in the U.S.
5.1.1.2. Increasing government investments in R&D of cancer treatment
5.1.2. Restraints
5.1.2.1. High cost of treatment and limited skilled personnel to perform radiotherapy
5.1.3. Opportunities
5.1.3.1. Technological advancements in radiotherapy such as computer technology and advanced engineering
5.1.4. Challenges
5.1.4.1. Adverse effects of radiotherapy
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Radiotherapy Market, by Product
6.1. Introduction
6.2. Conventional Cobalt-60 Teletherapy Units
6.3. Conventional Linear Accelerators
6.4. Electron-Emitting High-Energy Linear Accelerators
6.5. External Beam Radiotherapy
6.6. Internal Beam Radiotherapy or Brachytherapy
6.7.1. Afterloaders
6.7.2. Applicators
6.7.3. IORT Systems
6.7. Particle Therapy Systems
6.8.1. Cyclotrons
6.8.2. Synchrocyclotron
6.8.3. Synchrotrons
6.8. Stereotactic Advanced Electron or Cobalt-60 Linear Accelerators
6.9.1. CyberKnife
6.9.2. Gamma Knife
6.9.3. TomoTherapy
6.9. Systemic Radiotherapy
6.10.1. Iobenguane (I-131)
6.10.2. Rhenium-186
6.10.3. Samarium-153

7. Radiotherapy Market, by Procedure
7.1. Introduction
7.2. External Beam Radiotherapy
7.3.1. 3D Conformal Radiotherapy
7.3.2. Image-Guided Radiotherapy
7.3.3. Intensity-Modulated Radiotherapy
7.3.4. Particle Therapy
7.3.5. Stereotactic Therapy
7.3. Instillation Radiotherapy
7.4. Internal Beam Radiotherapy or Brachytherapy
7.5.1. High-Dose-Rate Brachytherapy
7.5.2. Low-Dose-Rate Brachytherapy
7.5.3. Pulsed-Dose-Rate Brachytherapy
7.5. Intravenous Radiotherapy
7.6. Oral Radiotherapy
7.7. Systemic Radiotherapy

8. Radiotherapy Market, by Application
8.1. Introduction
8.2. Breast Cancer
8.3. Cervical Cancer
8.4. Colorectal Cancer
8.5. Gynecological Cancer
8.6. Head & Neck Cancer
8.7. Lung Cancer
8.8. Penile Cancer
8.9. Prostate Cancer

9. Radiotherapy Market, by End-User
9.1. Introduction
9.2. Hospitals
9.3. Independent Radiotherapy Centers

10. California Radiotherapy Market
10.1. Introduction

11. Florida Radiotherapy Market
11.1. Introduction

12. Illinois Radiotherapy Market
12.1. Introduction

13. New York Radiotherapy Market
13.1. Introduction

14. Ohio Radiotherapy Market
14.1. Introduction

15. Pennsylvania Radiotherapy Market
15.1. Introduction

16. Texas Radiotherapy Market
16.1. Introduction

17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis, By Key Player
17.3. Market Share Analysis, By Key Player
17.4. Product Portfolio Analysis, By Key Player
17.5. Competitive Scenario
17.5.1. Merger & Acquisition
17.5.2. Agreement, Collaboration, & Partnership
17.5.3. New Product Launch & Enhancement
17.5.4. Investment & Funding
17.5.5. Award, Recognition, & Expansion

18. Company Usability Profiles
18.1. Accuray Incorporated
18.2. Becton, Dickinson and Company
18.3. Elekta AB
18.4. General Electric Company
18.5. IBA Worldwide
18.6. IntraOp Medical, Inc.
18.7. Koninklijke Philips N.V.
18.8. Leo Cancer Care
18.9. Mevion Medical Systems
18.10. Panacea Medical Technologies Pvt. Ltd.
18.11. Qfix
18.12. Radiology Oncology Systems
18.13. Varian Medical Systems, Inc.
18.14. ViewRay Technologies, Inc.
18.15. ZEISS Group

19. Appendix
19.1. Discussion Guide
19.2. License & Pricing

List of Figures
FIGURE 1. UNITED STATES RADIOTHERAPY MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES RADIOTHERAPY MARKET SIZE, 2022 VS 2030
FIGURE 3. UNITED STATES RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. UNITED STATES RADIOTHERAPY MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 5. UNITED STATES RADIOTHERAPY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. UNITED STATES RADIOTHERAPY MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 7. UNITED STATES RADIOTHERAPY MARKET DYNAMICS
FIGURE 8. UNITED STATES RADIOTHERAPY MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 9. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 10. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. UNITED STATES RADIOTHERAPY MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT, 2030
FIGURE 12. UNITED STATES RADIOTHERAPY MARKET SIZE, BY CONVENTIONAL COBALT-60 TELETHERAPY UNITS, 2018-2030 (USD MILLION)
FIGURE 13. UNITED STATES RADIOTHERAPY MARKET SIZE, BY CONVENTIONAL LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
FIGURE 14. UNITED STATES RADIOTHERAPY MARKET SIZE, BY ELECTRON-EMITTING HIGH-ENERGY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
FIGURE 15. UNITED STATES RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2018-2030 (USD MILLION)
FIGURE 16. UNITED STATES RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2018-2030 (USD MILLION)
FIGURE 17. UNITED STATES RADIOTHERAPY MARKET SIZE, BY AFTERLOADERS, 2018-2030 (USD MILLION)
FIGURE 18. UNITED STATES RADIOTHERAPY MARKET SIZE, BY APPLICATORS, 2018-2030 (USD MILLION)
FIGURE 19. UNITED STATES RADIOTHERAPY MARKET SIZE, BY IORT SYSTEMS, 2018-2030 (USD MILLION)
FIGURE 20. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
FIGURE 21. UNITED STATES RADIOTHERAPY MARKET SIZE, BY CYCLOTRONS, 2018-2030 (USD MILLION)
FIGURE 22. UNITED STATES RADIOTHERAPY MARKET SIZE, BY SYNCHROCYCLOTRON, 2018-2030 (USD MILLION)
FIGURE 23. UNITED STATES RADIOTHERAPY MARKET SIZE, BY SYNCHROTRONS, 2018-2030 (USD MILLION)
FIGURE 24. UNITED STATES RADIOTHERAPY MARKET SIZE, BY STEREOTACTIC ADVANCED ELECTRON OR COBALT-60 LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
FIGURE 25. UNITED STATES RADIOTHERAPY MARKET SIZE, BY CYBERKNIFE, 2018-2030 (USD MILLION)
FIGURE 26. UNITED STATES RADIOTHERAPY MARKET SIZE, BY GAMMA KNIFE, 2018-2030 (USD MILLION)
FIGURE 27. UNITED STATES RADIOTHERAPY MARKET SIZE, BY TOMOTHERAPY, 2018-2030 (USD MILLION)
FIGURE 28. UNITED STATES RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
FIGURE 29. UNITED STATES RADIOTHERAPY MARKET SIZE, BY IOBENGUANE (I-131), 2018-2030 (USD MILLION)
FIGURE 30. UNITED STATES RADIOTHERAPY MARKET SIZE, BY RHENIUM-186, 2018-2030 (USD MILLION)
FIGURE 31. UNITED STATES RADIOTHERAPY MARKET SIZE, BY SAMARIUM-153, 2018-2030 (USD MILLION)
FIGURE 32. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2022 VS 2030 (%)
FIGURE 33. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 34. UNITED STATES RADIOTHERAPY MARKET COMPETITIVE STRATEGIC WINDOW, BY PROCEDURE, 2030
FIGURE 35. UNITED STATES RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2018-2030 (USD MILLION)
FIGURE 36. UNITED STATES RADIOTHERAPY MARKET SIZE, BY 3D CONFORMAL RADIOTHERAPY, 2018-2030 (USD MILLION)
FIGURE 37. UNITED STATES RADIOTHERAPY MARKET SIZE, BY IMAGE-GUIDED RADIOTHERAPY, 2018-2030 (USD MILLION)
FIGURE 38. UNITED STATES RADIOTHERAPY MARKET SIZE, BY INTENSITY-MODULATED RADIOTHERAPY, 2018-2030 (USD MILLION)
FIGURE 39. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY, 2018-2030 (USD MILLION)
FIGURE 40. UNITED STATES RADIOTHERAPY MARKET SIZE, BY STEREOTACTIC THERAPY, 2018-2030 (USD MILLION)
FIGURE 41. UNITED STATES RADIOTHERAPY MARKET SIZE, BY INSTILLATION RADIOTHERAPY, 2018-2030 (USD MILLION)
FIGURE 42. UNITED STATES RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2018-2030 (USD MILLION)
FIGURE 43. UNITED STATES RADIOTHERAPY MARKET SIZE, BY HIGH-DOSE-RATE BRACHYTHERAPY, 2018-2030 (USD MILLION)
FIGURE 44. UNITED STATES RADIOTHERAPY MARKET SIZE, BY LOW-DOSE-RATE BRACHYTHERAPY, 2018-2030 (USD MILLION)
FIGURE 45. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PULSED-DOSE-RATE BRACHYTHERAPY, 2018-2030 (USD MILLION)
FIGURE 46. UNITED STATES RADIOTHERAPY MARKET SIZE, BY INTRAVENOUS RADIOTHERAPY, 2018-2030 (USD MILLION)
FIGURE 47. UNITED STATES RADIOTHERAPY MARKET SIZE, BY ORAL RADIOTHERAPY, 2018-2030 (USD MILLION)
FIGURE 48. UNITED STATES RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
FIGURE 49. UNITED STATES RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 50. UNITED STATES RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 51. UNITED STATES RADIOTHERAPY MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2030
FIGURE 52. UNITED STATES RADIOTHERAPY MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
FIGURE 53. UNITED STATES RADIOTHERAPY MARKET SIZE, BY CERVICAL CANCER, 2018-2030 (USD MILLION)
FIGURE 54. UNITED STATES RADIOTHERAPY MARKET SIZE, BY COLORECTAL CANCER, 2018-2030 (USD MILLION)
FIGURE 55. UNITED STATES RADIOTHERAPY MARKET SIZE, BY GYNECOLOGICAL CANCER, 2018-2030 (USD MILLION)
FIGURE 56. UNITED STATES RADIOTHERAPY MARKET SIZE, BY HEAD & NECK CANCER, 2018-2030 (USD MILLION)
FIGURE 57. UNITED STATES RADIOTHERAPY MARKET SIZE, BY LUNG CANCER, 2018-2030 (USD MILLION)
FIGURE 58. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PENILE CANCER, 2018-2030 (USD MILLION)
FIGURE 59. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PROSTATE CANCER, 2018-2030 (USD MILLION)
FIGURE 60. UNITED STATES RADIOTHERAPY MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 61. UNITED STATES RADIOTHERAPY MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 62. UNITED STATES RADIOTHERAPY MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USER, 2030
FIGURE 63. UNITED STATES RADIOTHERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
FIGURE 64. UNITED STATES RADIOTHERAPY MARKET SIZE, BY INDEPENDENT RADIOTHERAPY CENTERS, 2018-2030 (USD MILLION)
FIGURE 65. CALIFORNIA RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 66. FLORIDA RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 67. ILLINOIS RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 68. NEW YORK RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 69. OHIO RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 70. PENNSYLVANIA RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 71. TEXAS RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 72. UNITED STATES RADIOTHERAPY MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 73. UNITED STATES RADIOTHERAPY MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 74. UNITED STATES RADIOTHERAPY MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. UNITED STATES RADIOTHERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. UNITED STATES RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. UNITED STATES RADIOTHERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 5. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. UNITED STATES RADIOTHERAPY MARKET SIZE, BY CONVENTIONAL COBALT-60 TELETHERAPY UNITS, 2018-2030 (USD MILLION)
TABLE 7. UNITED STATES RADIOTHERAPY MARKET SIZE, BY CONVENTIONAL COBALT-60 TELETHERAPY UNITS, BY STATE, 2018-2030 (USD MILLION)
TABLE 8. UNITED STATES RADIOTHERAPY MARKET SIZE, BY CONVENTIONAL LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
TABLE 9. UNITED STATES RADIOTHERAPY MARKET SIZE, BY CONVENTIONAL LINEAR ACCELERATORS, BY STATE, 2018-2030 (USD MILLION)
TABLE 10. UNITED STATES RADIOTHERAPY MARKET SIZE, BY ELECTRON-EMITTING HIGH-ENERGY LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
TABLE 11. UNITED STATES RADIOTHERAPY MARKET SIZE, BY ELECTRON-EMITTING HIGH-ENERGY LINEAR ACCELERATORS, BY STATE, 2018-2030 (USD MILLION)
TABLE 12. UNITED STATES RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 13. UNITED STATES RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, BY STATE, 2018-2030 (USD MILLION)
TABLE 14. UNITED STATES RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 15. UNITED STATES RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, BY STATE, 2018-2030 (USD MILLION)
TABLE 16. UNITED STATES RADIOTHERAPY MARKET SIZE, BY AFTERLOADERS, 2018-2030 (USD MILLION)
TABLE 17. UNITED STATES RADIOTHERAPY MARKET SIZE, BY AFTERLOADERS, BY STATE, 2018-2030 (USD MILLION)
TABLE 18. UNITED STATES RADIOTHERAPY MARKET SIZE, BY APPLICATORS, 2018-2030 (USD MILLION)
TABLE 19. UNITED STATES RADIOTHERAPY MARKET SIZE, BY APPLICATORS, BY STATE, 2018-2030 (USD MILLION)
TABLE 20. UNITED STATES RADIOTHERAPY MARKET SIZE, BY IORT SYSTEMS, 2018-2030 (USD MILLION)
TABLE 21. UNITED STATES RADIOTHERAPY MARKET SIZE, BY IORT SYSTEMS, BY STATE, 2018-2030 (USD MILLION)
TABLE 22. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY SYSTEMS, BY STATE, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES RADIOTHERAPY MARKET SIZE, BY CYCLOTRONS, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES RADIOTHERAPY MARKET SIZE, BY CYCLOTRONS, BY STATE, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES RADIOTHERAPY MARKET SIZE, BY SYNCHROCYCLOTRON, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES RADIOTHERAPY MARKET SIZE, BY SYNCHROCYCLOTRON, BY STATE, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES RADIOTHERAPY MARKET SIZE, BY SYNCHROTRONS, 2018-2030 (USD MILLION)
TABLE 29. UNITED STATES RADIOTHERAPY MARKET SIZE, BY SYNCHROTRONS, BY STATE, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES RADIOTHERAPY MARKET SIZE, BY STEREOTACTIC ADVANCED ELECTRON OR COBALT-60 LINEAR ACCELERATORS, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES RADIOTHERAPY MARKET SIZE, BY STEREOTACTIC ADVANCED ELECTRON OR COBALT-60 LINEAR ACCELERATORS, BY STATE, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES RADIOTHERAPY MARKET SIZE, BY CYBERKNIFE, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES RADIOTHERAPY MARKET SIZE, BY CYBERKNIFE, BY STATE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES RADIOTHERAPY MARKET SIZE, BY GAMMA KNIFE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES RADIOTHERAPY MARKET SIZE, BY GAMMA KNIFE, BY STATE, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES RADIOTHERAPY MARKET SIZE, BY TOMOTHERAPY, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES RADIOTHERAPY MARKET SIZE, BY TOMOTHERAPY, BY STATE, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, BY STATE, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES RADIOTHERAPY MARKET SIZE, BY IOBENGUANE (I-131), 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES RADIOTHERAPY MARKET SIZE, BY IOBENGUANE (I-131), BY STATE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES RADIOTHERAPY MARKET SIZE, BY RHENIUM-186, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES RADIOTHERAPY MARKET SIZE, BY RHENIUM-186, BY STATE, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES RADIOTHERAPY MARKET SIZE, BY SAMARIUM-153, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES RADIOTHERAPY MARKET SIZE, BY SAMARIUM-153, BY STATE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES RADIOTHERAPY MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, BY STATE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES RADIOTHERAPY MARKET SIZE, BY 3D CONFORMAL RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES RADIOTHERAPY MARKET SIZE, BY 3D CONFORMAL RADIOTHERAPY, BY STATE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES RADIOTHERAPY MARKET SIZE, BY IMAGE-GUIDED RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES RADIOTHERAPY MARKET SIZE, BY IMAGE-GUIDED RADIOTHERAPY, BY STATE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES RADIOTHERAPY MARKET SIZE, BY INTENSITY-MODULATED RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES RADIOTHERAPY MARKET SIZE, BY INTENSITY-MODULATED RADIOTHERAPY, BY STATE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PARTICLE THERAPY, BY STATE, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES RADIOTHERAPY MARKET SIZE, BY STEREOTACTIC THERAPY, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES RADIOTHERAPY MARKET SIZE, BY STEREOTACTIC THERAPY, BY STATE, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES RADIOTHERAPY MARKET SIZE, BY INSTILLATION RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES RADIOTHERAPY MARKET SIZE, BY INSTILLATION RADIOTHERAPY, BY STATE, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES RADIOTHERAPY MARKET SIZE, BY INTERNAL BEAM RADIOTHERAPY OR BRACHYTHERAPY, BY STATE, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES RADIOTHERAPY MARKET SIZE, BY HIGH-DOSE-RATE BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES RADIOTHERAPY MARKET SIZE, BY HIGH-DOSE-RATE BRACHYTHERAPY, BY STATE, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES RADIOTHERAPY MARKET SIZE, BY LOW-DOSE-RATE BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES RADIOTHERAPY MARKET SIZE, BY LOW-DOSE-RATE BRACHYTHERAPY, BY STATE, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PULSED-DOSE-RATE BRACHYTHERAPY, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PULSED-DOSE-RATE BRACHYTHERAPY, BY STATE, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES RADIOTHERAPY MARKET SIZE, BY INTRAVENOUS RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES RADIOTHERAPY MARKET SIZE, BY INTRAVENOUS RADIOTHERAPY, BY STATE, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES RADIOTHERAPY MARKET SIZE, BY ORAL RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES RADIOTHERAPY MARKET SIZE, BY ORAL RADIOTHERAPY, BY STATE, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES RADIOTHERAPY MARKET SIZE, BY SYSTEMIC RADIOTHERAPY, BY STATE, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES RADIOTHERAPY MARKET SIZE, BY BREAST CANCER, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES RADIOTHERAPY MARKET SIZE, BY BREAST CANCER, BY STATE, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES RADIOTHERAPY MARKET SIZE, BY CERVICAL CANCER, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES RADIOTHERAPY MARKET SIZE, BY CERVICAL CANCER, BY STATE, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES RADIOTHERAPY MARKET SIZE, BY COLORECTAL CANCER, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES RADIOTHERAPY MARKET SIZE, BY COLORECTAL CANCER, BY STATE, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES RADIOTHERAPY MARKET SIZE, BY GYNECOLOGICAL CANCER, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES RADIOTHERAPY MARKET SIZE, BY GYNECOLOGICAL CANCER, BY STATE, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES RADIOTHERAPY MARKET SIZE, BY HEAD & NECK CANCER, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES RADIOTHERAPY MARKET SIZE, BY HEAD & NECK CANCER, BY STATE, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES RADIOTHERAPY MARKET SIZE, BY LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES RADIOTHERAPY MARKET SIZE, BY LUNG CANCER, BY STATE, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PENILE CANCER, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PENILE CANCER, BY STATE, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PROSTATE CANCER, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES RADIOTHERAPY MARKET SIZE, BY PROSTATE CANCER, BY STATE, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES RADIOTHERAPY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES RADIOTHERAPY MARKET SIZE, BY HOSPITALS, BY STATE, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES RADIOTHERAPY MARKET SIZE, BY INDEPENDENT RADIOTHERAPY CENTERS, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES RADIOTHERAPY MARKET SIZE, BY INDEPENDENT RADIOTHERAPY CENTERS, BY STATE, 2018-2030 (USD MILLION)
TABLE 97. CALIFORNIA RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 98. CALIFORNIA RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. CALIFORNIA RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 100. CALIFORNIA RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. CALIFORNIA RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. FLORIDA RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 103. FLORIDA RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. FLORIDA RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 105. FLORIDA RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. FLORIDA RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. ILLINOIS RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 108. ILLINOIS RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. ILLINOIS RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 110. ILLINOIS RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. ILLINOIS RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. NEW YORK RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 113. NEW YORK RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. NEW YORK RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 115. NEW YORK RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. NEW YORK RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. OHIO RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 118. OHIO RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. OHIO RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 120. OHIO RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. OHIO RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. PENNSYLVANIA RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 123. PENNSYLVANIA RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. PENNSYLVANIA RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 125. PENNSYLVANIA RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. PENNSYLVANIA RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. TEXAS RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 128. TEXAS RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. TEXAS RADIOTHERAPY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 130. TEXAS RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. TEXAS RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. UNITED STATES RADIOTHERAPY MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 133. UNITED STATES RADIOTHERAPY MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 134. UNITED STATES RADIOTHERAPY MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 135. UNITED STATES RADIOTHERAPY MARKET RANKING, BY KEY PLAYER, 2022
TABLE 136. UNITED STATES RADIOTHERAPY MARKET SHARE, BY KEY PLAYER, 2022
TABLE 137. UNITED STATES RADIOTHERAPY MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 138. UNITED STATES RADIOTHERAPY MARKET MERGER & ACQUISITION
TABLE 139. UNITED STATES RADIOTHERAPY MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 140. UNITED STATES RADIOTHERAPY MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 141. UNITED STATES RADIOTHERAPY MARKET INVESTMENT & FUNDING
TABLE 142. UNITED STATES RADIOTHERAPY MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 143. UNITED STATES RADIOTHERAPY MARKET: LICENSE & PRICING

Companies Mentioned

  • Accuray Incorporated
  • Becton, Dickinson and Company
  • Elekta AB
  • General Electric Company
  • IBA Worldwide
  • IntraOp Medical, Inc.
  • Koninklijke Philips N.V.
  • Leo Cancer Care
  • Mevion Medical Systems
  • Panacea Medical Technologies Pvt. Ltd.
  • Qfix
  • Radiology Oncology Systems
  • Varian Medical Systems, Inc.
  • ViewRay Technologies, Inc.
  • ZEISS Group

Methodology

Loading
LOADING...